メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
栗山 直英
医学部・麻酔・侵襲制御医学
h-index
397
被引用数
12
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2011
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(47)
類似のプロファイル
(7)
フィンガープリント
Naohide Kuriyamaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Keyphrases
Adsorption Kinetics
38%
NETosis
38%
Interleukin-6
38%
Continuous Venovenous Hemodiafiltration (CVVHDF)
38%
Blood Droplet
38%
Microfluidic Assay
38%
Transpulmonary Thermodilution
38%
Differential Injection
38%
Cold Saline
38%
Return Temperature
38%
Blood Differentials
38%
Blood Return
38%
Decreased Cardiac Output
38%
Cytokine Removal
38%
Circulating Histones
38%
Disseminated mucormycosis
38%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
38%
Critically Ill Patients
38%
Polymyxin B-immobilized Fiber Column
38%
Venous Thromboembolism Prevention
38%
Management Center
38%
Antibiotic-associated Encephalopathy
38%
Cefepime Hydrochloride
38%
Chamber Structure
38%
Multicenter Observational Study
38%
Blood Type O
38%
Polymyxin B-immobilized Fiber Column-direct Hemoperfusion
38%
Hemoperfusion Therapy
38%
PMX-DHP
38%
MDA-MB-231 Cancer Cells
38%
Ionic Interaction
38%
Rectus Sheath Hematoma
38%
In Vitro Evaluation
38%
Positional Change
38%
Protein Removal
38%
Burn Patients
38%
Ubiquinone-10
38%
Continuous Hemodiafiltration
38%
Lopinavir
38%
Adult Cardiac
38%
Severe Acute Kidney Injury
38%
Lipodystrophy Syndrome
38%
Pancreatic Injury
38%
Transsylvian
38%
Insular Lesion
38%
Heschl's Gyrus
38%
Prismaflex
25%
Mucormycosis
19%
FTase Inhibitor
19%
Serum Chloride Level
19%
Medicine and Dentistry
Acute Kidney Injury
83%
Observational Study
76%
Intensive Care Unit
48%
Interleukin-6
38%
Linezolid
38%
COVID-19
38%
Brain Disease
38%
Hyperchloremia
38%
Liver Transplantation
38%
Liver Polycystic Disease
38%
Tumor Lysis Syndrome
38%
Histone H3
38%
Mucormycosis
38%
Antiinfective Agent
38%
Cohort Analysis
38%
Polymyxin B
38%
Hemoperfusion
38%
Continuous Hemodiafiltration
38%
Hemodynamic
38%
Transesophageal Echocardiography
38%
Urinary System
38%
Blood Purification
38%
Venous Thromboembolism
38%
Cefepime
38%
Extracorporeal Membrane Oxygenation
38%
Neutrophil Gelatinase Associated Lipocalin
38%
Myoglobin
38%
Lipodystrophy
38%
Lopinavir/Ritonavir
38%
Pancreatic Injury
38%
Continuous Kidney Replacement Therapy
25%
Poly(methyl Methacrylate)
25%
Hemodiafiltration
25%
Bleeding
19%
Serum Chloride
17%
Highly Active Antiretroviral Therapy
17%
Pathogen Associated Molecular Pattern
15%
Infection
14%
Renal Replacement Therapy
13%
Cardiovascular Surgery
12%
Cardiopulmonary Bypass
12%
Hepatomegaly
12%
Cephalosporin Derivative
12%
Posterior Insula
12%
Language Test
12%
Continuous Hemofiltration
12%
Echography
11%
Pulmonary Embolism
11%
Neurologic Disease
10%
Acute Respiratory Distress Syndrome
9%
Pharmacology, Toxicology and Pharmaceutical Science
Sepsis
100%
Disease
76%
Coronavirinae
76%
Septic Shock
46%
Brain Disease
38%
Lethality
38%
Muscle Weakness
38%
Epileptic Absence
38%
Burkitt's Lymphoma
38%
Thrombomodulin
38%
Cefepime
38%
Polymyxin B
38%
Hemoperfusion
38%
Triple Negative Breast Cancer
38%
Interferon Type I
38%
Lipopolysaccharide
38%
Tumor Lysis Syndrome
38%
Antiinfective Agent
38%
Lopinavir Plus Ritonavir
38%
Pancreas Injury
38%
Lipodystrophy
38%
Autoantibodies
38%
Interleukin 6
26%
Cytokine
26%
Chemotherapy
23%
Infection
22%
Catecholamine
15%
Interleukin 1
15%
Pathogen Associated Molecular Pattern
15%
Adsorption
15%
Cephalosporin Derivative
14%
Nafamstat
11%
Weakness
10%
Neurologic Disease
10%
Tipifarnib
9%
Penicillin Derivative
9%
Anuria
7%
Tumor Necrosis Factor
7%
Inflammation
7%
Sodium Chloride
7%
Severe Renal Impairment
7%
Ischemia
7%
Organ Dysfunction Score
7%
Synapsin I
7%
Endocannabinoid
7%
Survival Rate
7%
Mouse
7%
Adult Respiratory Distress Syndrome
7%
Endothelium Injury
7%
Poly(methyl Methacrylate)
7%
